MC2-R Double Nickase Plasmid (h): sc-402854-NIC
- Target species: human
- 20 µg of transfection-ready, purified plasmid DNA; Suitable for up to 20 transfections
- MC2-R Double Nickase Plasmid (h) consists of a pair of plasmids each encoding a D10A mutated Cas9 nuclease and a target-specific 20 nt guide RNA (gRNA) designed to knockout gene expression with greater specificity than its CRISPR/Cas9 KO counterpart
- Paired gRNA sequences are offset by approximately 20 bp to allow for specific Cas9-mediated double nicking of the genomic DNA, which mimics a DSB
- One plasmid in the pair contains a puromycin-resistance gene for selection; the other plasmid in the pair contains a GFP marker to visually confirm transfection
- MC2-R Double Nickase Plasmid (h) and MC2-R Double Nickase Plasmid (h2) encode distinct paired gRNA designs targeting MC2R. One or both designs may be available
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
MC2-R Double Nickase Plasmid (h) | sc-402854-NIC | 20 µg | $410.00 | |||
MC2-R Double Nickase Plasmid (h2) | sc-402854-NIC-2 | 20 µg | $410.00 |
MC2R encodes melanocortin 2 receptor (MC2-R), a G protein-coupled receptor that is selectively activated by adrenocorticotropic hormone (ACTH) to stimulate Gs/cAMP/PKA signaling in adrenal cortical cells. This pathway regulates steroidogenic gene expression, including key enzymes controlling glucocorticoid biosynthesis and broader adrenal stress responses. MC2-R function is coordinated with accessory factors such as MRAP to support receptor trafficking and ACTH responsiveness, linking membrane signaling to transcriptional control of steroidogenesis. Genetic or functional disruption of MC2R is associated with impaired ACTH signaling and disorders of adrenal steroid production, making it a relevant target for endocrine pathway and stress-axis research.
MC2-R Double Nickase Plasmid (h) consists of a matched pair of plasmids engineered for high-specificity editing of the MC2R locus in human cell lines. Each plasmid expresses a Cas9 D10A nickase and a distinct sgRNA targeting opposite DNA strands within MC2R. When directed to adjacent sites on opposite DNA strands, the two nickases generate offset single-strand nicks that together produce a staggered double-strand break, requiring coordinated on-target activity from both guides. The resulting DNA break is resolved by endogenous cellular repair pathways, most commonly through non-homologous end joining (NHEJ), leading to insertions or deletions that disrupt MC2R function. By requiring dual sgRNA engagement at the target locus, the double nicking approach enhances editing specificity and provides a complementary CRISPR strategy for applications where additional control over targeting precision is desired.
To support efficient identification of edited cells, one plasmid encodes GFP for fluorescent visualization of transfected populations, while the companion plasmid carries a puromycin resistance gene for antibiotic selection. Together, these features support efficient enrichment of co-transfected populations and simplify the validation of MC2R-disrupted clones.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.